Back | Next |
home / stock / rdhl / rdhl message board
Subject | By | Source | When |
---|---|---|---|
$RDHL must see | midastouch017 | investorshub | 04/20/2023 8:24:10 AM |
Lets go go go go... Up up and away we go. | midastouch017 | investorshub | 04/20/2023 5:06:04 AM |
$RDHL oh yeah news for the day | midastouch017 | investorshub | 04/20/2023 4:18:28 AM |
bears are running | midastouch017 | investorshub | 04/20/2023 1:45:26 AM |
bulls and bears | midastouch017 | investorshub | 04/20/2023 12:34:27 AM |
$RDHL Price trading | midastouch017 | investorshub | 04/19/2023 11:55:52 PM |
$RDHL great article | Spideyboy | investorshub | 04/19/2023 8:28:49 PM |
bears are running | Spideyboy | investorshub | 04/19/2023 8:14:25 AM |
$RDHL what do you make of this data? | midastouch017 | investorshub | 04/18/2023 8:25:52 PM |
got some short data | midastouch017 | investorshub | 04/18/2023 6:42:12 PM |
Price gaining | midastouch017 | investorshub | 04/18/2023 12:07:47 PM |
$RDHL Found an interesting article | midastouch017 | investorshub | 04/18/2023 10:26:14 AM |
$RDHL What do you make of this? | seve333 | investorshub | 04/18/2023 4:10:30 AM |
The now last trade up | midastouch017 | investorshub | 04/18/2023 12:43:36 AM |
$RDHL great news | midastouch017 | investorshub | 04/18/2023 12:40:21 AM |
$RDHL short data if anyone is interested | midastouch017 | investorshub | 04/18/2023 12:34:45 AM |
MomentumIts now | midastouch017 | investorshub | 04/17/2023 10:59:52 PM |
MomentumIts trading up | midastouch017 | investorshub | 04/17/2023 3:17:57 PM |
Do we have a winner?Turn around time? | carusso | investorshub | 04/17/2023 9:44:06 AM |
$RDHL short squeeze all day | carusso | investorshub | 04/17/2023 9:26:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 PR Newswire The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035 and adds to opaganib's ...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study PR Newswire First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat) 1 for early COVID-19 outpatient treatment, funded through non-...
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire RedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base ...